β-lapachone is a bioactivatable chemotherapeutic agent that directly targets cancer cell lines over-expressing NQO1, leading to the interruption of glycolytic metabolism and changes in the redox state of the cell [9]. The gene discussed is NQO1; the disease is cancer.